Biotechnology company Impel NeuroPharma revealed on Monday the election of Lynn C. Gold, PhD as the senior vice president of Regulatory Affairs.
In the senior position in the company, Gold has extensive oversight of regulatory strategy, agency communication as well as regulatory submissions
Most recently, Gold has served as vice president of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services LLC as well as vice president of its Research and Process Development at Sonus Pharmaceuticals.
Previously, Gold worked with Warner Chilcott Laboratories, Naryx Pharmaceuticals as well as Pharmacia and Upjohn.
Currently, Gold is a member of AAPS and the American Chemical Society (ACS) and Drug Information Association (DIA).
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA